XML 61 R23.htm IDEA: XBRL DOCUMENT v3.20.1

STOCKHOLDERS' EQUITY

3 Months Ended

Mar. 31, 2020

Equity [Abstract]

STOCKHOLDERS' EQUITY

STOCKHOLDERS’ EQUITY

Share Repurchase Program

On November 14, 2018, the Board of Directors approved the extension of the Company’s existing stock repurchase program for an additional three-year period and authorized up to an additional $100 million in repurchases. Stock repurchases under this program may be made in the open market or in private transactions at times and in amounts determined by the Company. As of March 31, 2020, $60.2 million remained available under the program.

Common and Preferred Stock

The Board of Directors has the authority to issue common and unclassed preferred stock of up to 200 million shares and 25 million shares, respectively, with par value of $0.01 per share, as well as to fix dividends, voting and conversion rights, redemption provisions, liquidation preferences and other rights and restrictions.

Accumulated Other Comprehensive Income

Changes in AOCI by component, net of tax, for the three months ended March 31, 2020 are summarized as follows (in thousands):

						Foreign Currency Translation and Other						Derivative Instruments						Total
Balances at December 31, 2019						$	(1,866)					$	(2,112)					$	(3,978)
Net unrealized gains (losses) arising during the period(a)						(1,636)						(5,217)						(6,853)
Less: Net realized gains (losses) reclassified to net (loss) income(b)						—						(1,334)						(1,334)
Net change during the period						(1,636)						(3,883)						(5,519)
Balances at March 31, 2020						(3,502)						(5,995)						(9,497)

—————————

^(a) Derivative instruments net of $1,759 thousand of tax benefit for the three months ended March 31, 2020.

^(b) Derivative instruments net of $451 thousand of tax benefit for the three months ended March 31, 2020.

Changes in AOCI by component, net of tax, for the three months ended March 31, 2019 are summarized as follows (in thousands):

						Foreign Currency Translation and Other						Derivative Instruments						Total
Balances at December 31, 2018						$	(2,578)					$	(765)					$	(3,343)
Net unrealized gains (losses) arising during the period(c)						298						(939)						(641)
Less: Net realized gains (losses) reclassified to net income(d)						—						(125)						(125)
Net change during the period						298						(814)						(516)
Balances at March 31, 2019						(2,280)						(1,579)						(3,859)

—————————

^(c) Derivative instruments net of $308 thousand of tax benefit for the three months ended March 31, 2019.

^(d) Derivative instruments net of $42 thousand of tax benefit for the three months ended March 31, 2019.

X

- References

No definition available.

+ Details

Name:	us-gaap_EquityAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-URI http://asc.fasb.org/topic&trid=2208762

+ Details

Name:	us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration